Characterization of microbial communities from gut microbiota of hypercholesterolemic and control subjects

IntroductionIn recent years, several studies have evidenced the importance of the microbiome to host physiology as metabolism regulator, along with its potential role in triggering various diseases. In this study, we analyzed the gut microbiota in hypercholesterolemic (cases) and normocholesterolemi...

Full description

Bibliographic Details
Main Authors: Cristian Morales, Gabriel Rojas, Camilo Rebolledo, Marcelo Rojas-Herrera, Raúl Arias-Carrasco, Sara Cuadros-Orellana, Vinicius Maracaja-Coutinho, Kathleen Saavedra, Pamela Leal, Fernando Lanas, Luis A. Salazar, Nicolás Saavedra
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2022.943609/full
_version_ 1798013815988682752
author Cristian Morales
Cristian Morales
Gabriel Rojas
Camilo Rebolledo
Marcelo Rojas-Herrera
Marcelo Rojas-Herrera
Raúl Arias-Carrasco
Sara Cuadros-Orellana
Vinicius Maracaja-Coutinho
Kathleen Saavedra
Pamela Leal
Fernando Lanas
Luis A. Salazar
Nicolás Saavedra
author_facet Cristian Morales
Cristian Morales
Gabriel Rojas
Camilo Rebolledo
Marcelo Rojas-Herrera
Marcelo Rojas-Herrera
Raúl Arias-Carrasco
Sara Cuadros-Orellana
Vinicius Maracaja-Coutinho
Kathleen Saavedra
Pamela Leal
Fernando Lanas
Luis A. Salazar
Nicolás Saavedra
author_sort Cristian Morales
collection DOAJ
description IntroductionIn recent years, several studies have evidenced the importance of the microbiome to host physiology as metabolism regulator, along with its potential role in triggering various diseases. In this study, we analyzed the gut microbiota in hypercholesterolemic (cases) and normocholesterolemic (controls) individuals to identify characteristic microbial signature for each condition.MethodsStool samples were obtained from 57 adult volunteers (27 hypercholesterolemic and 30 controls). The taxonomic profiling of microbial communities was performed using high-throughput sequencing of 16S rRNA V3-V4 amplicons, followed by data analysis using Quantitative Insights Into Microbial Ecology 2 (QIIME2) and linear discriminant analysis (LDA) effect size (LEfSe).ResultsSignificant differences were observed in weight, height, body mass index (BMI) and serum levels of triglycerides, total cholesterol and low-density lipoprotein cholesterol (LDL-C) between the groups (p<0.05). LEfSe showed differentially abundant prokaryotic taxa (α=0.05, LDA score > 2.0) in the group of hypercholesterolemic individuals (Methanosphaera, Rothia, Chromatiales, Clostridiales, Bacillaceae and Coriobacteriaceae) and controls (Faecalibacterium, Victivallis and Selenomonas) at various taxonomic levels. In addition, through the application of Phylogenetic Investigation of Communities by Reconstruction of Unobserved States 2 (PICRUSt2), the predominance of pathways related to biosynthesis in hypercholesterolemic patients was established, compared to controls in which degradation pathways were predominant. Finally, in the analysis of co-occurrence networks, it was possible to identify associations between the microorganisms present in both studied groups.ConclusionOur results point out to unique microbial signatures, which likely play a role on the cholesterol metabolism in the studied population.
first_indexed 2024-04-11T15:07:33Z
format Article
id doaj.art-d091bb7edd4c48e3b20bad139911a86f
institution Directory Open Access Journal
issn 2235-2988
language English
last_indexed 2024-04-11T15:07:33Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj.art-d091bb7edd4c48e3b20bad139911a86f2022-12-22T04:16:44ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882022-11-011210.3389/fcimb.2022.943609943609Characterization of microbial communities from gut microbiota of hypercholesterolemic and control subjectsCristian Morales0Cristian Morales1Gabriel Rojas2Camilo Rebolledo3Marcelo Rojas-Herrera4Marcelo Rojas-Herrera5Raúl Arias-Carrasco6Sara Cuadros-Orellana7Vinicius Maracaja-Coutinho8Kathleen Saavedra9Pamela Leal10Fernando Lanas11Luis A. Salazar12Nicolás Saavedra13Centro de Biología Molecular y Farmacogenética, Núcleo Científico-Tecnológico en Biorecursos BIOREN, Universidad de La Frontera, Temuco, ChileTecnología Médica, Facultad de Salud, Universidad Santo Tomás, Temuco, ChileCentro de Biología Molecular y Farmacogenética, Núcleo Científico-Tecnológico en Biorecursos BIOREN, Universidad de La Frontera, Temuco, ChileCentro de Biología Molecular y Farmacogenética, Núcleo Científico-Tecnológico en Biorecursos BIOREN, Universidad de La Frontera, Temuco, ChileCentro de Genética y Genómica, Facultad de Medicina, Universidad del Desarrollo, Santiago, ChileSubdepartamento de Genética Molecular, Instituto de Salud Pública de Chile, Santiago, ChilePrograma Institucional de Fomento a la Investigación, Desarrollo e Innovación, Universidad Tecnológica Metropolitana, Santiago, ChileCentro de Biotecnología de los Recursos Naturales, Facultad de Ciencias Agrarias y Forestales, Universidad Católica del Maule, Talca, ChileAdvanced Center for Chronic Diseases - ACCDiS, Facultad de Química y Ciencias Farmacéuticas, Universidad de Chile, Santiago, ChileCentro de Biología Molecular y Farmacogenética, Núcleo Científico-Tecnológico en Biorecursos BIOREN, Universidad de La Frontera, Temuco, ChileDepartamento de Ciencias Agronómicas y Recursos Naturales, Facultad de Ciencias Agropecuarias y Medioambiente, Temuco, ChileDepartamento de Medicina Interna, Facultad de Medicina, Universidad de La Frontera, Temuco, ChileCentro de Biología Molecular y Farmacogenética, Núcleo Científico-Tecnológico en Biorecursos BIOREN, Universidad de La Frontera, Temuco, ChileCentro de Biología Molecular y Farmacogenética, Núcleo Científico-Tecnológico en Biorecursos BIOREN, Universidad de La Frontera, Temuco, ChileIntroductionIn recent years, several studies have evidenced the importance of the microbiome to host physiology as metabolism regulator, along with its potential role in triggering various diseases. In this study, we analyzed the gut microbiota in hypercholesterolemic (cases) and normocholesterolemic (controls) individuals to identify characteristic microbial signature for each condition.MethodsStool samples were obtained from 57 adult volunteers (27 hypercholesterolemic and 30 controls). The taxonomic profiling of microbial communities was performed using high-throughput sequencing of 16S rRNA V3-V4 amplicons, followed by data analysis using Quantitative Insights Into Microbial Ecology 2 (QIIME2) and linear discriminant analysis (LDA) effect size (LEfSe).ResultsSignificant differences were observed in weight, height, body mass index (BMI) and serum levels of triglycerides, total cholesterol and low-density lipoprotein cholesterol (LDL-C) between the groups (p<0.05). LEfSe showed differentially abundant prokaryotic taxa (α=0.05, LDA score > 2.0) in the group of hypercholesterolemic individuals (Methanosphaera, Rothia, Chromatiales, Clostridiales, Bacillaceae and Coriobacteriaceae) and controls (Faecalibacterium, Victivallis and Selenomonas) at various taxonomic levels. In addition, through the application of Phylogenetic Investigation of Communities by Reconstruction of Unobserved States 2 (PICRUSt2), the predominance of pathways related to biosynthesis in hypercholesterolemic patients was established, compared to controls in which degradation pathways were predominant. Finally, in the analysis of co-occurrence networks, it was possible to identify associations between the microorganisms present in both studied groups.ConclusionOur results point out to unique microbial signatures, which likely play a role on the cholesterol metabolism in the studied population.https://www.frontiersin.org/articles/10.3389/fcimb.2022.943609/fullgut microbiotaLDL cholesterolLEfSe analysismicrobial signature16S rRNA sequencing
spellingShingle Cristian Morales
Cristian Morales
Gabriel Rojas
Camilo Rebolledo
Marcelo Rojas-Herrera
Marcelo Rojas-Herrera
Raúl Arias-Carrasco
Sara Cuadros-Orellana
Vinicius Maracaja-Coutinho
Kathleen Saavedra
Pamela Leal
Fernando Lanas
Luis A. Salazar
Nicolás Saavedra
Characterization of microbial communities from gut microbiota of hypercholesterolemic and control subjects
Frontiers in Cellular and Infection Microbiology
gut microbiota
LDL cholesterol
LEfSe analysis
microbial signature
16S rRNA sequencing
title Characterization of microbial communities from gut microbiota of hypercholesterolemic and control subjects
title_full Characterization of microbial communities from gut microbiota of hypercholesterolemic and control subjects
title_fullStr Characterization of microbial communities from gut microbiota of hypercholesterolemic and control subjects
title_full_unstemmed Characterization of microbial communities from gut microbiota of hypercholesterolemic and control subjects
title_short Characterization of microbial communities from gut microbiota of hypercholesterolemic and control subjects
title_sort characterization of microbial communities from gut microbiota of hypercholesterolemic and control subjects
topic gut microbiota
LDL cholesterol
LEfSe analysis
microbial signature
16S rRNA sequencing
url https://www.frontiersin.org/articles/10.3389/fcimb.2022.943609/full
work_keys_str_mv AT cristianmorales characterizationofmicrobialcommunitiesfromgutmicrobiotaofhypercholesterolemicandcontrolsubjects
AT cristianmorales characterizationofmicrobialcommunitiesfromgutmicrobiotaofhypercholesterolemicandcontrolsubjects
AT gabrielrojas characterizationofmicrobialcommunitiesfromgutmicrobiotaofhypercholesterolemicandcontrolsubjects
AT camilorebolledo characterizationofmicrobialcommunitiesfromgutmicrobiotaofhypercholesterolemicandcontrolsubjects
AT marcelorojasherrera characterizationofmicrobialcommunitiesfromgutmicrobiotaofhypercholesterolemicandcontrolsubjects
AT marcelorojasherrera characterizationofmicrobialcommunitiesfromgutmicrobiotaofhypercholesterolemicandcontrolsubjects
AT raulariascarrasco characterizationofmicrobialcommunitiesfromgutmicrobiotaofhypercholesterolemicandcontrolsubjects
AT saracuadrosorellana characterizationofmicrobialcommunitiesfromgutmicrobiotaofhypercholesterolemicandcontrolsubjects
AT viniciusmaracajacoutinho characterizationofmicrobialcommunitiesfromgutmicrobiotaofhypercholesterolemicandcontrolsubjects
AT kathleensaavedra characterizationofmicrobialcommunitiesfromgutmicrobiotaofhypercholesterolemicandcontrolsubjects
AT pamelaleal characterizationofmicrobialcommunitiesfromgutmicrobiotaofhypercholesterolemicandcontrolsubjects
AT fernandolanas characterizationofmicrobialcommunitiesfromgutmicrobiotaofhypercholesterolemicandcontrolsubjects
AT luisasalazar characterizationofmicrobialcommunitiesfromgutmicrobiotaofhypercholesterolemicandcontrolsubjects
AT nicolassaavedra characterizationofmicrobialcommunitiesfromgutmicrobiotaofhypercholesterolemicandcontrolsubjects